| Name | Title | Affiliation | Working Group |
| Ach, Johann | Dr | Centrum für Bioethik Universität Münster | Ethical and Societal Impact |
| Adams, John | Prof | Emeritus Professor, Geography Department, University College London | Regulation |
| Adcock, Mike | Dr | Lecturer, Department of Law, Durham University, UK | Regulation |
| Bührlen, Bernhard | Competence-Center 'Emerging technologies', Fraunhofer Institute for Systems and Innovation Research (ISI) | Economic Impact | |
| Bennett, David | Dr | Nanobio-RAISE EC Science & Society Project, St Edmund's College, University of Cambridge and Delft University of Technology, The Netherlands & Director, Cambridge Biomedical C | Coordinator |
| Berger, Francois | Dr | National Institute of Health and Medical Research, Grenoble, France Member of the INSERM Ethics committee Member of Nano2Life Ethical, Legal and Social Aspects Board |
Economic Impact |
| Beringer, John | Prof Sir | formerly Pro Vice-Chancellor, University of Bristol and who led the independent review of the UK Government's response to the 2004 Royal Society & Royal Academy of Engineering nanotechnology report | Chairman |
| Birch, Hayley | Science Writer/Editor | Communication | |
| Bruce, Donald | Dr | formerly Director, Church of Scotland, Society,0 Religion and Technology Project, Edinburgh, UK Managing Director, Edinethics Ltd. | Ethical and Societal Impact |
| Cózar-Escalante, José Manuel de | Prof | Department of History and Philosophy of Science, University of La Laguna, Spain | Ethical and Societal Impact |
| Cantley, Mark | Mr | formerly Adviser, Life Sciences and Biotechnology, Directorate-General for Research, European Commission | Convener Regulation |
| Charbit, Françoise | Dr | Technological Research Division, Commissariat à l'Énergie Atomique (CEA), Grenoble, France | Convener Economic Impact |
| Chi, Serene K. | Ms | Working Group on Biotechnology and Society, Technology University of Delft; Sheffield Institute of Biotechnological Law and Ethics | Coordination assistant, Regulation |
| D'Silva, Joel | PhD student, University of Leuven | Regulation | |
| Daly, Avril | Fighting Blindness, Ireland Genetic and Rare Disorders Organisation www.fightingblindness.ie | Patient Needs | |
| Donaldson, Ken | Prof | Professor of Respiratory Toxicology, The Medical School, University of Edinburgh | Regulation |
| Dorbeck-Jung, Bärbel.R. | Dr. | Associate Professor of Legal Governance,University of Twente, Faculty of Management and Governance | Regulation |
| Epprecht, Thomas K. | Dr | Director, Underwriting Products, Swiss Reinsurance Company | Regulation |
| Est, Rinie van | Researcher Technology Assessment, Rathenau Instituut | Communication | |
| Floch, Lorraine Le | Independent patient | Patients Need | |
| Friedrichs, Steffi | Dr | Director, Nanotechnology Industry Association | Regulation |
| Fuchs, Harald | Prof. Dr. | Physikalisches Institut, Westf. Wilhelms-Universität Münster | Communication |
| Gabellieri, Cristina | Dr | European Commission | Steering Committee |
| Gaspar, Rogerio | Prof | Professor Pharmaceutics, Faculdade de Farmácia da Universidade de Lisboa | Regulation |
| Geertsma, Robert | Project Leader / Senior Scientist, National Institute for Public Health and the Environment (RIVM), The Netherlands Projects: EU Observatory Nano, Framing Nano, Nano Interact (and many other projects) www.rivm.nl | Ethical and Societal Impact | |
| Gilbert, Laura | Freelance Research Consultant | Patients Need | |
| Gonsalkorala, Mahendra | Dr | European Parkinson's Disease Association | Patients Need |
| Grobe, Antje | Dr. | Stiftung Risiko-Dialog, Winterthur | Communication |
| Haraszti Marton | Dr | European Commission | |
| Hatto, Peter | Dr | Director of Research, IonBond Ltd. Chairman ISO TC 229, CEN TC 352 and BSI NTI/1 Nanotechnologies standardization committees | Regulation |
| Hayhurst, Richard | Hayhurst Media www.hayhurstmedia.com | Media Relation | |
| Heckl, Wolfgang | Prof | Ludwig-Maximilians-Universität; Director General of the Deutsches Museum, München, Germany | Communication |
| Hillier, Melissa | Genetic Interest Group www.gig.org.uk | Patient Needs | |
| Hirschfeld, Jurgen | Dr | Bayer Schering Pharma | Regulation |
| Hix, Paul | Deutsches Museum, München, Germany | Communication | |
| Jensen, Uffe Juul | Prof | Professor of Philosophy of Medicine and Health Care, Director of Research Center: Health, Human and Culture Department, University of Aarhus, Denmark Visiting Senior fellow, Bios, LSE, London | Ethical and Societal Impact |
| Jordan, Andreas | Dr | MagForce Nanotechnologies AG, Berlin, Germany | Communication |
| Kearns, Peter | Dr | Head, OECD Biosafety Programme and Secretary, OECD Working Party on Manufactured Nanomaterials, Paris | Regulation |
| Kent, Alastair | Mr | Director, Genetic Interest Group, UK and Chairman, European Platform for Patients' Organisations, Science and Industry (EPPOSI) | Patient Needs |
| Kernbach, Ulrich | Deutsches Museum, München, Germany | Communication | |
| Kinderlerer, Julian | Prof | Delft University of Technology, The Netherlands & University of Cape Town, South Africa and member of the European Commission's European Group on Ethics. | Coordinator, Convener WP5 |
| Kohl, Thorsten | Dr | Technology University of Darmstadt | Ethical and Societal Impact |
| Korakianiti, Evdokia | Dr | Scientific Administrator, Human Unit, Pre-Authorisation, Quality of Medicines Sector, European Medicines Agency (EMEA) | Regulation |
| Krug, Harald F. | Dr | EMPA Materials Science & Technology, St. Gallen, Switzerland Project: NanoCare, NanoHealth (Germany); Impart, NanoMMVNB, NanoImpactNet (EC); many Egyet Groups | Communication |
| Levy, Laurent | Dr | CEO, Nanobiotix, France | Economic Impact |
| Müller, Sabine | Dr | Institut für Geschichte, Theorie und Ethik der Medizin, Universitätsklinikum Aachen | Ethical and Societal Impact |
| M'RINI, Christine | MD,Dr | Directeur Scientifique Merieux Alliance | Economic Impact |
| Macnaghten, Phil | Prof | Department of Geography, Durham University, UK Project: DEEPEN | Communication |
| Meade, Nick | Genetic Interest Group | Patients Need | |
| Mitchell, Rod | formerly Chairman, European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) | Patient Needs | |
| Moslonka-Lefebvre, Mathieu | OECD Secretariat for the Working Party on Manufactured Nanomaterials | Regulation (External Observer) | |
| Nordmann, Alfred | Prof | Technische Universität Darmstadt, Germany & University of South Carolina, USA | Convener Ethical and Societal Impact |
| Nunes, João Arriscado | Prof | Professor of Sociology, Center for Social Studies, University of Coimbra, Portugal Project: DEEPEN(EC), ESF, SNSN | Ethical and Societal Impact |
| Pohler, Wiebke | LMU München | Communication | |
| Sanna Liuska | European Patients' Forum | Patient Needs | |
| Schillmeier, Michael | Dr. | Institut für Soziologie, LMU München | Communication |
| Schmidt, Helmut | Prof | EPG Engineered nanoProducts Germany AG, Saarbrücken, Germany | Communication |
| Siebold, Horst | Dr | Siemens Health Care | Regulation |
| Slobbe, Rob | Dr. | Senior Director Q&R Philips Corporate Technologies | Regulation |
| Smidt, Cees | European Genetic Alliances' Network (EGAN) | Patient Needs | |
| Smit, Paul | Dr | Strategy and Business Development, Philips Medical Systems, The Nederlands Project: ETP NanoMedicine | Economic Impact |
| Solbakk, Jan Helge | Prof | Adjunct Professor in Philosophy of Medicine and Medical Ethics, Centre for International Health, University of Bergen & Professor and Professor, Section for Medical Ethics, Faculty of Medicine, University of Oslo | Ethical and Societal Impact |
| Sykes, Kathy | Prof. Dr. | Institute for Advanced Studies, University of Bristol | Communication |
| Thalheim, Christoph | Secretary General, European Multiple Sclerosis Platform (EMSP) | Patient Needs | |
| Velzen, Maaike van | Philips Health Care. Leader of the IPR Working Group in the Nano2Life project | Regulation | |
| Vericat, Joan Albert | Dr | Director, Preclinical Development at Neuropharma SA | Regulation |
| Walhout, Bart | Researcher Technology Assessment, Rathenau Instituut | Communication | |
| Weltring, Klaus-Michael | Dr | Nano2Life EC Network of Excellence & Managing Director, Bioanalytik Münster, Germany Project: ETP NanoMedicine | Coordinator, Regulation |
| Yu, Jiang | Dr | Institute of Policy and Management, Chinese Academy of Sciences | Regulation |